Literature DB >> 10086036

Scope and consequences of peptic ulcer disease. How important is asymptomatic Helicobacter pylori infection?

D Y Graham1, R E Rakel, A M Fendrick, M F Go, B J Marshall, D A Peura, J E Scherger.   

Abstract

H pylori infection is so common as to seem ubiquitous in many areas of the world. Transmission is believed to be primarily person to person. The pathogen invariably damages the gastric mucosa, resulting in both structural and functional abnormalities. It causes histologic gastritis and is critical in the pathogenesis of the gastritis-associated diseases, namely, gastric ulcer, duodenal ulcer, gastric adenocarcinoma, and primary gastric lymphoma. Elimination of the infection results in healing of gastritis and cure of peptic ulcer disease.

Entities:  

Mesh:

Year:  1999        PMID: 10086036     DOI: 10.3810/pgm.1999.03.593

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  4 in total

1.  Pattern and validity of clinical diagnosis of upper gastrointestinal diseases in south-west Nigeria.

Authors:  E A Agbakwuru; A O Fatusi; D A Ndububa; O I Alatise; O A Arigbabu; D O Akinola
Journal:  Afr Health Sci       Date:  2006-06       Impact factor: 0.927

2.  Patient preferences for the chemoprevention of colorectal cancer.

Authors:  Chin Hur; Darcy E Broughton; Chung Yin Kong; Elissa M Ozanne; Ethan B Richards; Thanh Truong; G Scott Gazelle
Journal:  Dig Dis Sci       Date:  2008-12-05       Impact factor: 3.199

3.  Expression of the programmed death ligand 1, B7-H1, on gastric epithelial cells after Helicobacter pylori exposure promotes development of CD4+ CD25+ FoxP3+ regulatory T cells.

Authors:  Ellen J Beswick; Irina V Pinchuk; Soumita Das; Don W Powell; Victor E Reyes
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

4.  Patient preferences for the chemoprevention of esophageal adenocarcinoma in Barrett's esophagus.

Authors:  Chin Hur; Darcy E Broughton; Elissa Ozanne; Patrick Yachimski; Norman S Nishioka; G Scott Gazelle
Journal:  Am J Gastroenterol       Date:  2008-09-04       Impact factor: 10.864

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.